117 related articles for article (PubMed ID: 37844486)
1. RUNX1 predicts poor prognosis and correlates with tumor progression in clear cell renal carcinoma.
Ma J; He S; Li M; Peng Y; Yang X; Chen L; Jia Q; Liu Y
Pathol Res Pract; 2023 Nov; 251():154886. PubMed ID: 37844486
[TBL] [Abstract][Full Text] [Related]
2. FBXO39 predicts poor prognosis and correlates with tumor progression in cervical squamous cell carcinoma.
Yang Y; Zhao Y; Sun G; Zuo S; Chai J; Xu T; Liu J; Li L; Song J; Qian S; Kang Y; Sui F; Li M; Jia Q
Pathol Res Pract; 2022 Oct; 238():154090. PubMed ID: 36049441
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
4. TRIM21 promotes tumor progression and cancer stemness in cervical squamous cell carcinoma.
Yang Y; Zuo S; Li W; Di M; Liu J; Chai J; Wang J; Yuan Y; Li M; Jia Q
Pathol Res Pract; 2023 Aug; 248():154710. PubMed ID: 37494805
[TBL] [Abstract][Full Text] [Related]
5. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
6. Clusterin promotes growth and invasion of clear cell renal carcinoma cell by upregulation of S100A4 expression.
Liu Y; Men C; Xu Y; Zhao K; Luo L; Dong D; Yu Q
Cancer Biomark; 2018; 21(4):915-923. PubMed ID: 29400663
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
8. MTHFD2 Overexpression Predicts Poor Prognosis in Renal Cell Carcinoma and is Associated with Cell Proliferation and Vimentin-Modulated Migration and Invasion.
Lin H; Huang B; Wang H; Liu X; Hong Y; Qiu S; Zheng J
Cell Physiol Biochem; 2018; 51(2):991-1000. PubMed ID: 30466107
[TBL] [Abstract][Full Text] [Related]
9. CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma.
Li T; Cheng Y; Wang P; Wang W; Hu F; Mo X; Lv H; Xu T; Han W
J Exp Clin Cancer Res; 2015 Oct; 34():122. PubMed ID: 26474560
[TBL] [Abstract][Full Text] [Related]
10. Formin-related protein 1 facilitates proliferation and aggressive phenotype of clear cell renal cell carcinoma through MAPK/MMP2 pathway.
Ma G; Zhang B; Fu S; Lu J; Zhang L; Shang P; Yue Z
Mol Cell Probes; 2023 Oct; 71():101921. PubMed ID: 37454877
[TBL] [Abstract][Full Text] [Related]
11. Novel long noncoding RNA OTUD6B-AS1 indicates poor prognosis and inhibits clear cell renal cell carcinoma proliferation via the Wnt/β-catenin signaling pathway.
Wang G; Zhang ZJ; Jian WG; Liu PH; Xue W; Wang TD; Meng YY; Yuan C; Li HM; Yu YP; Liu ZX; Wu Q; Zhang DM; Zhang C
Mol Cancer; 2019 Jan; 18(1):15. PubMed ID: 30670025
[TBL] [Abstract][Full Text] [Related]
12. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival.
Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G
Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253
[TBL] [Abstract][Full Text] [Related]
13. Expression patterns and prognostic value of RUNX genes in kidney cancer.
Gao K; Zhang F; Chen K; Li W; Guan YB; Xu ML; Chong T; Dai ZM
Sci Rep; 2021 Jul; 11(1):14934. PubMed ID: 34294773
[TBL] [Abstract][Full Text] [Related]
14. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
[TBL] [Abstract][Full Text] [Related]
15. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
Huang J; Wang X; Wen G; Ren Y
Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
[TBL] [Abstract][Full Text] [Related]
16. RUNX1 Is a Driver of Renal Cell Carcinoma Correlating with Clinical Outcome.
Rooney N; Mason SM; McDonald L; Däbritz JHM; Campbell KJ; Hedley A; Howard S; Athineos D; Nixon C; Clark W; Leach JDG; Sansom OJ; Edwards J; Cameron ER; Blyth K
Cancer Res; 2020 Jun; 80(11):2325-2339. PubMed ID: 32156779
[TBL] [Abstract][Full Text] [Related]
17. MiR-182-5p inhibits the tumorigenesis of clear cell renal cell carcinoma by repressing UBE2T.
Wu Y; Zhang C; Peng D; He S; Huang C; Qian J; Zhu W; Feng N; Gong Y; Li X; Zhou L
Hum Cell; 2022 Mar; 35(2):542-556. PubMed ID: 35129808
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine kinase 1 regulates lipid metabolism to promote progression of kidney renal clear cell carcinoma.
Zhao L; Wang Z; Xu Y; Zhang P; Qiu J; Nie D; Wu G; Chen C; Chang Y; Xia Q
Pathol Res Pract; 2023 Aug; 248():154641. PubMed ID: 37467634
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]